CryoLife, Inc. (NYSE:CRY)

CAPS Rating: 5 out of 5

The Company develops and commercializes biomaterials, implantable medical devices, and preserves and distributes human tissues for cardiovascular and vascular transplant applications.

Recs

0
Player Avatar Contralogic (< 20) Submitted: 1/31/2010 5:53:05 PM : Outperform Start Price: $6.39 CRY Score: -50.00

Good potential with Cryolife.

Featured Broker Partners


Advertisement